Navigation Links
MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
Date:2/25/2008

MaxLife Fund Corp. and Capital Growth Planning Inc., form "MaxLife-CGP" Partners LLC., a California based operation. "MaxLife-CGP" expects to build initial portfolios with approximately $25M to $100M dollars in face value of which the Joint Venture anticipates total transactions to exceed 1

Billion dollars in face throughout 2008.

CALIFORNIA, Feb. 25 /PRNewswire-FirstCall/ - MaxLife Fund Corp. (OTC:MXFD). MaxLife Fund Corp. ("MaxLife") and Capital Growth Planning, Inc. ("CGP"), are pleased to announce that they have entered into a joint venture, with each company having an equal interest. "MaxLife-CGP", will acquire life settlement insurance policies for its own inventory, and for resale purposes to institutional buyers.

MaxLife and CGP are working together to fund the new joint venture. It is anticipated that the joint venture will be funded by institutional and private funds. The funding will enable "MaxLife-CGP" to execute its business plan of building initial portfolios of approximately $25M to $100M in face value for resale. Throughout 2008, "MaxLife-CGP's" goal is to develop life settlement policy transactions exceeding $1 billion in total face value. "MaxLife-CGP" will manage all phases of policy acquisitions, settlement and sourcing, back-office support, portfolio building structures and resale strategies.

"We are pleased to partner with a company such as Capital Growth Planning Inc., which has over 35 years experience in the insurance industry. Capital Growth Planning Inc. has exclusive and new innovative products for the fast growing life settlement market. As the life settlement market becomes one of the fastest growing sectors, we expect MaxLife Fund Corp. to expand its operations and create value for our shareholders," stated Mr. Bennett Kurtz, MaxLife Fund Corp., CEO.

Mr. Douglas W. Miller, the CEO of "CGP" quoted, "Capital Growth Planning is extremely excited to be expanding its life settlement purchase/resale strategies through its Joint Venture with MaxLife. A considerable amount of resources and time have been spent toward developing these purchase strategies and the relationships necessary to transact business in this space. Over the last two years, "CGP", has settled and resold, and/or brokered the sale of over 55 policies totaling over $40M in life insurance policy face. "MaxLife-CGP" allows "MaxLife" and "CGP" to coordinate their respective strengths to make this Joint Venture a successful revenue enterprise for both firms."

About Capital Growth Planning, Inc.: Capital Growth Planning, Inc., "CGP", was formed in 1969 as a diversified financial services corporation. "CGP" is the parent company of eight wholly-owned subsidiaries that collectively have designed multiple financial products and programs ("Financial Structures") to take advantage of the significant revenue opportunities to be realized in the life settlement market, the life insurance market, and the broker-dealer securities and advisory markets. Over the last several years, "CGP" has primarily focused in developing and implementing comprehensive structured life settlement brokerage, principal protected investment and securities programs, and premium finance life insurance products. February 1, 2008, "CGP" filed a Provisional Patent Application to protect its proprietary protection "Life Insurance Backed Collateral" investment structure, otherwise known as LIBAC(SM). Other financial services include advanced tax reduction planning and retirement planning. "CGP's" primary role is managing its subsidiary companies, while developing, promoting and marketing its highly specialized, exclusive, and/or proprietary insurance and financial products through joint ventures, wholesale distribution, and/or syndication. "CGP" primarily focuses on products and services that are innovative, structurally sophisticated, and conducive to specific market niches that currently have little or no product/service representation. "CGP's" executive management team has over 250 years combined experience and the average employment of its executives is 23 years.

About MaxLife Fund Corp.: MaxLife Fund Corp. is concentrating on 3 major components of the fast growing Life Settlement sector; to invest in policies for our own inventory, to trade policies in the open market and to build a large portfolio by demand for institutional buyers. MaxLife Fund Corp. is positioning itself to grow with the industry and expand its operation to become one of the leaders in the Life Settlement sector.

Cautionary Statement Pursuant to Safe Harbor Provisions of the Private

Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. The Company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this news release.

For further information contact:

MaxLife Fund Corp.

1-866-752-5557


'/>"/>
SOURCE MaxLife Fund Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
2. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
3. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
4. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
5. MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc.
6. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
7. MBF Healthcare Acquisition Corp. Announces Signing of Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc.
8. HMS Holdings Corp. Hosts Fourth Quarter and Full Year 2007 Financial Teleconference and Presentation
9. HMS Holdings Corp. to Present at 2008 UBS Global Healthcare Services Conference
10. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
11. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... Thomas Vas-Don suffered from severe injury due ... was able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ... the principals of massage, anatomy , trigger points and referral pain patterns ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Gevir, a ... deer antler velvet, announced its products are coming soon to Amazon.com, the world’s largest ... Shelley Thomson as a means to develop an effective natural treatment for Shelley’s Multiple ...
(Date:2/22/2017)... ... , ... The National Academy of Certified Care Managers (NACCM) ... testing period. NACCM, a nonprofit organization, has provided the premier certification for Care ... re-calibrated to ensure that newly certified professionals are prepared to work effectively on ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... with chronic conditions reported skipping doses or not filling a prescription because they ... under-insured, rates of cost-related problems getting medications were 30-60%*. At the ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified ... from the mouth into the bloodstream. Far outpacing the absorption speed ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... MARIETTA, Ga., Feb. 23, 2017  MiMedx Group, Inc. ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of ... quarter and full year ended December 31, 2016. ... Revenue is a 31% increase over full year ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic ... 9.2% over the next decade to reach approximately $8.9 billion by ... forecasts for all the given segments on global as well as ...
(Date:2/23/2017)... 23, 2017  Spheryx, Inc. will present ... at PittCon 2017 Conference and Exposition at ... world,s largest annual premier conference and exposition ... array of industry, academic and government communities ... food safety, environmental, bioterrorism and other emerging ...
Breaking Medicine Technology: